MEDICA 2019
headset which it hopes will replace the usual mask and mouthpiece which has been prevalent up until now.
The headset measures expiratory oxygen,
respiratory volume and the pulse, and an app calculates personal fitness, fat burned and the basal metabolic rate. The patented system enables users to analyse their performance without a mask, and provides coaching to optimise the individual’s weight and performance with a precision that, up until now, could only be obtained using expensive and cumbersome medical devices. A total of 13 other start-ups will present innovative solutions for measuring blood pressure, lab-on-skin technology and biomarker analysis, during the session. The subsequent Medica Disrupt session is dedicated to women’s health. One start-up, viMUM will demonstrate how modern antenatal prep for parents could look using e- learning modules that can be called up in an app. The viMUM experts consist of midwives, gynaecologists, paediatricians, psychologists and dietitians who provide qualified support to expectant parents when they are called on. Other start-ups in this session show breastfeeding apps, a smart wireless stethoscope for babies and children, and a wireless cardiotocography system (iCTG) for monitoring foetal wellbeing.
Cognitive and mental health
The Medica Disrupt session taking place at 11am on Thursday 21 November will be dedicated to cognitive and mental health. Michele Maltese, CEO and co-founder of Avanix, will present a modern system for monitoring patients with Alzheimer’s, among other elements. OiX Care enables professional carers to monitor Alzheimer’s patients around the clock. The system consists of a transmitter (OiX Sensor) which is worn by the patient, and a receiver (OiX Receiver) that enables the carer to monitor the person. OiX communicates in real time through an ISM radiofrequency protocol. The device does not require a telephone or network connection to transfer information from the patient to the carer, and has a range of 200 metres indoors and three kilometres outdoors.
Another app – Mindance - focuses on increasing wellbeing by functioning as a personal assistant, providing meditations,
OCTOBER 2019
relaxation exercises and applying the latest findings from the world of psychology. All of this is available in one app that would be suited to companies, where it could be used to boost occupational health. Employees could, for example, be given personalised mental training via the app. Robin Maier, CEO and founder, will explain how this concept could work.
Treating chronic conditions using new methods
Following this session, the future for treating chronic illnesses will be illuminated. Start- ups will show innovations for treating high blood pressure and other cardiovascular conditions via non-invasive measurement of blood glucose, ranging from glaucoma to chronic pain. Using light will be a key theme. The CareWear light patch produces blue and red light in order to relieve pain and improve tissue regeneration by boosting local blood circulation and elevating the tissue temperature. The light patches emit wavelengths of light that warm tissues. This makes the muscles relax and stimulates circulation. Information on the wireless CareWear light patches will be presented by Dr Chris Castel (CEO). Further sessions on Medica’s closing day (21 November) will revolve around artificial intelligence (AI), big data and how AI is used to classify and document ulcers and wounds. While the Medica Disrupt sessions offer
start-ups a stage for speakers and their presentations, the Medica Start-up Park in Hall 13 will provide a fixed meeting point throughout the entire run of the trade fair, ensuring that contact can be made with these young companies who are headed for success, and to provide a platform for discussing their creative product concepts. Last year’s winner of the Innovation World Cup (in the healthcare category), was the start-up StethoMe. This year, the start-up registered to take part in the Medica Start-up Park to demonstrate StethoMe, a wireless stethoscope which lets parents check their children’s lung and heart function themselves, and enables them to share the data with a doctor via an app. In November, the month of the trade fair,
it’s certain that flu season will already have taken hold. A wrong diagnosis and negligent treatment can lead to dangerous
complications for a few cases, such as lung infections and bronchitis. The Polish development team from SensDx, who will also be present at the Medica Start-up Park, will demonstrate a multi-sensor which enables a quick test to be carried out to diagnose infections of the upper respiratory tract. Easy to use, a swab sample is taken which is then placed in a solution contained in a capsule, and then put a compact measuring device. The sensor can detect a flu virus in its early stages, which is important in enabling the doctor to select the correct therapy and prevent unnecessary prescriptions of antibiotics which don’t work on viral infections. Rehago, from Reutlingen University, is a German start-up that will be presenting virtual reality applications that can be used as a training activity in rehabilitation of hemiplegic patients, patients with muscular spasms or hemispatial neglect (an attention disorder caused by brain lesions). Intento, a Swiss company, is also active in the rehabilitation field. At Medica 2019, it will present an application that aids patients who have been severely paralysed by strokes, in recovering the motor function in their upper limbs. The system revolves around functional electrical stimulation, and requires no prior knowledge on how to place electrodes, or time-consuming steps to configure the system. The rehabilitation application from Intento consists of a tablet application for therapists and a device for controlling movement (for the patient) that is linked to an electrical stimulator. More than 30 start-ups will participate in the Medica Start-up Park - six of them benefiting from the support provided by the Merck Group’s global accelerator programme. This science and technology company, predominantly driven by research, is based in Darmstadt and supports start-ups, with the objective of entering into a partnership with them. Besides funding, the Merck Group offers access to the facilities and venues at the Merck Innovation Center - as well as the opportunity to join a network of over 50,000 experts and alumni in 67 countries.
Visitor information is available for both Medica and Compamed at
www.medica-tradefair.com and
www.compamed-tradefair.com
WWW.CLINICALSERVICESJOURNAL.COM I 71
CSJ
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84
